GW Pharmaceuticals plc
GB ˙ LSE ˙ GB0030544687
TEN SYMBOL NIE JEST JUŻ AKTYWNY
SecurityGB:GWP / GW Pharmaceuticals plc
InstitutionFT Options LLC
Latest Disclosed Ownership36,847 shares
Latest Disclosed Value $ 3,740,000
FT Options LLC ownership in GWP / GW Pharmaceuticals plc

On November 13, 2017 - FT Options LLC filed a 13F-HR form disclosing ownership of 36,847 shares of GW Pharmaceuticals plc (GB:GWP) valued at $3,740,000 USD as of September 30, 2017. The entity filed a previous 13F-HR on August 11, 2017 disclosing 33,557 shares of GW Pharmaceuticals plc. This represents a change in shares of 9.80% during the quarter.

FT Options LLC has a history of taking positions in derivatives of the underlying security (GWP) in the form of stock options. The firm currently holds call options representing 9,100 of underlying shares valued at $34,000 USD and put options representing 71,000 of underlying shares valued at $1,320,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:GWP / GW Pharmaceuticals plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2017-11-13 2017-09-30 13F GW PHARMACEUTICALS ADS 36197T103 36,847 3,290 9.80 3,740 11.18 5.6361
2017-08-11 2017-06-30 13F GW PHARMACEUTICALS ADS 36197T103 33,557 7,728 29.92 3,364 7.68
2017-05-12 2017-03-31 13F GW PHARMACEUTICALS ADS 36197T103 25,829 -25,471 3,124
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-11-13 2017-09-30 13F GW PHARMACEUTICALS ADS Call 9,100 0.00 34 -17.07 n/a n/a n/a
2017-08-11 2017-06-30 13F GW PHARMACEUTICALS ADS Call 9,100 0.00 41 -67.20 n/a n/a n/a
2017-05-12 2017-03-31 13F GW PHARMACEUTICALS ADS Call 9,100 -92.96 125 -94.23 n/a n/a n/a
2017-02-10 2016-12-31 13F GW PHARMACEUTICALS ADS Call 129,200 -1.45 2,166 -57.98 n/a n/a n/a
2016-11-10 2016-09-30 13F GW PHARMACEUTICALS ADS Call 131,100 1.00 5,155 235.83 n/a n/a n/a
2016-08-12 2016-06-30 13F GW PHARMACEUTICALS ADS Call 129,800 68.57 1,535 111.14 n/a n/a n/a
2016-05-09 2016-03-31 13F GW PHARMACEUTICALS ADS Call 77,000 98.45 727 148.12 n/a n/a n/a
2016-02-05 2015-12-31 13F GW PHARMACEUTICALS ADS Call 38,800 293 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-11-13 2017-09-30 13F GW PHARMACEUTICALS ADS Put 71,000 32.46 1,320 4.76 n/a n/a n/a
2017-08-11 2017-06-30 13F GW PHARMACEUTICALS ADS Put 53,600 -5.30 1,260 83.14 n/a n/a n/a
2017-05-12 2017-03-31 13F GW PHARMACEUTICALS ADS Put 56,600 -30.64 688 -4.58 n/a n/a n/a
2017-02-10 2016-12-31 13F GW PHARMACEUTICALS ADS Put 81,600 3.42 721 99.17 n/a n/a n/a
2016-11-10 2016-09-30 13F GW PHARMACEUTICALS ADS Put 78,900 73.41 362 7.10 n/a n/a n/a
2016-08-12 2016-06-30 13F GW PHARMACEUTICALS ADS Put 45,500 52.17 338 33.07 n/a n/a n/a
2016-05-09 2016-03-31 13F GW PHARMACEUTICALS ADS Put 29,900 -41.72 254 -78.67 n/a n/a n/a
2016-02-05 2015-12-31 13F GW PHARMACEUTICALS ADS Put 51,300 1,191 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.